Intercompany loans can be considered useful in the following scenarios: the intercompany loan is the amount lent by one company (in one group) to another company (in the same group) for various purposes, including to support the cash flows of the borrowing company, finance fixed assets or finance the normal activities of the borrowing company that has RT on the interest of the lending company and interest charges for the company borrower. Let`s take a look at the intercompany credit calculations: even if intercompany loans are treated as assets and liabilities in the relevant units, these balances must be eliminated at the time of group consolidation. As with other loans, the borrowing company is required to repay the amount of capital at the end of the credit period. Businesses cannot refuse to pay such payments, as such a refusal can have serious tax and regulatory repercussions on both companies. In summary, they are mainly intended for short-term financing, which facilitates the work of the statements in the same time. This is a simple credit agreement of intercompany that registers an uninsured loan between companies of the group. In the city of Rosario, province of Santa Fe, Argentine Republic, on the 14th day of March 2019 („date of entry into force“), on the one hand: BIOCERES SA, with registered office at Ocampo 210 bis, Property CCT, Indear Building, Rosario( hereinafter „BIOCERES“) and, on the other hand, BIOCERES CROP SOLUTIONS CORP. based at Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, Cayman Islands (now the Borrower) and jointly „The Parties“. This intercompany loan agreement (the „Agreement“) dated July 1, 2014 („Effective Date“) is entered into by and between 3D Pioneer Systems, Inc., a Nevada company („Lender“) and 3D Pioneer Systems Malta I Ltd., a Maltese company and a subsidiary of the Lender („Borrower“). This first amendment to the INTERCOMPANY LOAN AGREEMENT („Amendment“) will be entered into and completed on May 1, 2016 („Effective Date“) by and between NaturalShrimp Holdings, Inc., a Delaware corporation („NSH“), and NaturalShrimp Incorporated, a Nevada corporation (NSI). NSH and JSS may be referred to jointly as „parties“ in this amendment. INTERCOMPANY LOAN AGREEMENT (this „Agreement“), dated November 18, 2013, by and between Ampio Pharmaceuticals, Inc., a Delaware corporation („Lender“), and Vyrix Pharmaceuticals, Inc., a Delaware corporation („Borrower“), a 100% subsidiary of the Lender. .